Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.9 USD | -0.20% | -1.66% | -14.44% |
06/05 | Bristol-Myers Squibb Says Applications for Opdivo Accepted by US, European Regulators | MT |
06/05 | Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.44% | 89.17B | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Says FDA Accepts Supplemental Biologics License Application for Acute Graft Versus Host Disease Treatment